Daily Brief Archive: July 24, 2026 — U.S. & Hong Kong Stock Analysis
Free previewU.S. Markets
- Dow -0.97%, S&P -1.21%, Nasdaq -2.15% under the twin weight of earnings and oil
- TSLA -14.5% as margins hit 1.4%; GOOGL -7.1% on another $15B capex raise
- Tankers hit in the Red Sea; Brent +5% through $100, reigniting the inflation trade
- The 10-year at 4.707%, an 18-month high; claims at 187K show a still-strong labor market
- Defense and life-science beat-and-raises: LMT +10.5%, TMO +8.7%, RTX +7.3%
- INTC crushed estimates after hours, ripping +12% toward $110
Hong Kong
- The Hang Seng rose 1.28% to 25,211, back above 25,000; HS Tech +0.65%
- Southbound sold a net HK$4.23B; Tencent steadied +1% but is still -6.9% on the week
- Lithium erupted: Ganfeng H-shares +9.9%, A-share miners at limit-up, carbonate futures +5%
- Gold held at $4,119 as miners extend weekly-scale rallies (China Gold Intl +22.9% on the week)
- Cathay Pacific pre-announced H1 profit +62-76%; Citi double-upgraded to Buy
- Chip names pulled back: Hua Hong -7%, SMIC -3%
Today's Watchlist
- Wednesday 7/29: the FOMC decision collides with MSFT/META earnings after the close
- Thursday 7/30: AAPL/AMZN earnings plus US Q2 GDP
- PayPal's buyout talks resolve by end-July, with 7/28 earnings as mutual leverage
- COIN reports 7/30 with volumes tracking a third straight decline — our position is closed
- The month-end Politburo meeting sets H2 policy; China PMI lands 7/31
- HSBC reports 8/4: Goldman models +25% profit and a fresh $1.5B buyback
Deep Dives (0 names)
No deep-dive names match the current filters
Rapid Scan (9 names)
| Ticker | Close | Change | Score | Direction | One-line take |
|---|---|---|---|---|---|
 THRMUS | $45.61 | +26.52% | 6 | Neutral | A +26.5% triple hit — earnings blast, $400M buyback, a medical acquisition — fully priced in one small-cap session; chasing adds nothing |
 BLFSUS | $30.77 | -1.22% | 5 | Neutral | Up 22.7% on the month at RSI 66 — biopreservation small-cap strength, but no fresh catalyst, no chase |
 CASHUS | $83.12 | -6.26% | 5 | Neutral | A double miss with narrowing NIM and rising credit costs, -6.3% — the losing side of regional-bank earnings dispersion, sidelines |
 ECPGUS | $85.63 | -2.92% | 5 | Neutral | A -2.9% move on 5.3x volume in this debt-collection small cap, with no public explanation — understand the volume-price divergence before touching |
 FSBCUS | $47.35 | -2.11% | 5 | Neutral | A $44 offering priced it down on 13x volume — Q2 profit still grew sequentially, the business is fine; sidelines while placement shares digest |
 NVECUS | $134.21 | +54.83% | 5 | Neutral | +54.8% on an 81%-revenue quarter plus a $1 dividend — but chasing a small cap after a +55% day is pass-the-parcel; admire from a distance |
 CCSUS | $69.27 | +7.35% | 5 | Neutral | Up 7.3% with homebuilder strength, +10.8% on the month — small-cap builder beta, watch the retest |
 EVHUS | $4.64 | -16.70% | 5 | Neutral | Citi's downgrade knocked it -16.7% — the target actually rose to $6.75, but medical-cost doubts linger; oversold without a reason to catch |
 STCUS | $64.25 | -7.83% | 5 | Neutral | A big Q2 EPS miss ($1.39 vs. $1.63) gapped it -7.8% — an earnings kill in title-insurance small caps, sidelines |